TD Cowen has recently raised Sana Biotechnology Inc (SANA) stock to Buy rating, as announced on January 8, 2025, according to Finviz. Earlier, on November 5, 2024, JMP Securities had reduced the stock ...

NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ:SANA). Such investors are ...

As of Jan. 10, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum ...

Prime Minister Narendra Modi on Thursday released the genome sequencing data of 10,000 Indian nationals and said it will be a milestone in the field of biotechnology research. The Genome India ...

Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...

SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will ...

On Wednesday, Sana Biotechnology shares received an upgrade from TD Cowen analysts, shifting from a Hold to a Buy rating. The upgrade was prompted by Sana's announcement of positive interim study ...

On Wednesday, Sana Biotechnology (NASDAQ:SANA) shares witnessed a dramatic increase, surging over 300% following the market close. This leap came after the company announced promising results from the ...